Ligand Pharmaceuticals LGND Earnings Call Transcripts

NASDAQ LGND
$306.20 +7.20 (+2.41%)
At close: Nov 6, 2026 · 4:00 PM EST
13 earnings calls on file for Ligand Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Ligand Pharmaceuticals Q3 2026 Earnings Call

Oct 29, 2026 7,247 words · 32 min read
  • Melanie HermanHead of Investor Relations
  • Todd DavisChief Executive Officer
  • Octavio EspinozaChief Financial Officer
  • Lauren HayVice President of Portfolio Strategy and Investments
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Ligand Pharmaceuticals Earnings Call Transcripts

Calls13
LatestOct 29, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 13 Ligand Pharmaceuticals transcripts Register to get access to Ligand Pharmaceuticals’s earnings call transcripts.